Roscovitine [roskovitin]
- Terms
-
R-roskovitin
seliciclib
-
(2R)-2-((6-Benzylamino-9-(propan-2-yl)-9H-purin-2-yl)amino)butan-1-ol
2-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
CYC 202
CYC-202
CYC202
R-roscovitine
Seliciclib
A purine derivative and competitive inhibitor of CYCLIN-DEPENDENT KINASES that has therapeutic potential as an antineoplastic and antiviral agent.
- DUI
- D000077546 MeSH Browser
- CUI
- M0273114
- History note
- 2019 (1997)
- Public note
- 2019; ROSCOVITINE was indexed under PURINES 1997-2018
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 2
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 2
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine